| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-06-21 | Halaven® (eribulin) | advanced breast cancer | preclinical | Eisai (Japan) | Cancer - Oncology |
| 2016-06-21 | TD-6450 and faldaprevir | hepatitis C | 2a | Trek Therapeutics (USA - MA) | Infectious diseases |
| 2016-06-21 | Yeliva™ (ABC294640) | advanced solid tumors | 1 | Redhill Biopharma (Israel) | Cancer - Oncology |
| 2016-06-20 | Bekinda™(extended-release formulation of ondansetron) | irritable bowel syndrome | 2 | Redhill Biopharma (Israel) | Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
| 2016-06-20 | GBT440 | idiopathic pulmonary fibrosis and hypoxemia | 2a | Global Blood Therapeutics (USA - CA) | Lung diseases - Respiratory diseases - Rare diseases |
| 2016-06-20 | lefamulin (BC 3781) | preclinical | Nabriva Therapeutics (Austria) | Infectious diseases | |
| 2016-06-20 | bictegravir (GS-9883) | HIV-1 infection | 1 | Gilead Sciences (USA - CA) | Infectious diseases |
| 2016-06-17 | MOR208 | Non-Hodgkin's Lymphoma (NHL) | 2 | Morphosys (Germany) | Cancer - Oncology |
| 2016-06-17 | ABX203 | hepatitis B | 2b-3 | Abivax (France) | Infectious diseases |
| 2016-06-17 | ASN200 program including ASN-4 | multi-drug resistant Escherichia coli infection | preclinical | Arsanis (USA - MA) | Infectious diseases |
| 2016-06-17 | AM-111 | idiopathic sudden sensorineural hearing loss | 3 | Auris Medical (Switzerland) | Otorhinolaryngology |
| 2016-06-16 | pidilizumab | diffuse intrinsic pontine glioma (DIPG) | 1-2 | Hadassah Medical Organization (Israel) Medivation (USA - CA) | Cancer - Oncology - Rare diseases |
| 2016-06-16 | Keytruda® (pembrolizumab - MK-3475) | non-small-cell lung carcinoma | 3 | Merck&Co (USA - NJ) | Cancer - Oncology |
| 2016-06-16 | resminostat (oral pan-histone deacetylase (HDAC) inhibitor) | preclinical | 4SC (Germany) | Cancer - Oncology | |
| 2016-06-16 | ONS-3010 (biosimilar version of Humira® (adalimumab)) | moderate to severe plaque psoriasis | 3 | Oncobiologics (USA - NJ) | Autoimmune diseases - Dermatological diseases |
| 2016-06-15 | Apocept™ (APG101 - asunercept) | myelodysplastic syndromes | 1 | Apogenix (Germany) | Cancer - Oncology |
| 2016-06-14 | plitidepsin | angioimmunoblastic T-cell lymphoma | 2 | PharmaMar (Spain) | Cancer - Oncology - Rare diseases |
| 2016-06-13 | GALE-401 (anagrelide controlled release ) | 2 | Galena Biopharma (USA - OR) | Cancer - Oncology - Hematological diseases | |
| 2016-06-13 | SPK-8011 | hemophilia A | preclinical | Spark Therapeutics (USA - PA) | Rare diseases - Genetic diseases - Hematological diseases |
| 2016-06-12 | inotuzumab ozogamicin | relapsed or refractory CD22-positive acute lymphoblastic leukemia (ALL) | 3 | Pfizer (USA - NY) | Cancer - Oncology |
